A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)

Autor: Ang, Yvonne L. E.1 (AUTHOR), Zhao, Xiaotian2 (AUTHOR), Reungwetwattana, Thanyanan3 (AUTHOR), Cho, Byoung-Chul4 (AUTHOR), Liao, Bin-Chi5,6 (AUTHOR), Yeung, Rebecca7 (AUTHOR), Loong, Herbert H.8 (AUTHOR), Kim, Dong-Wan9 (AUTHOR), Yang, James Chih-Hsin5,6 (AUTHOR), Lim, Sun Min4 (AUTHOR), Ahn, Myung-Ju10 (AUTHOR) silkahn@skku.edu, Lee, Se-Hoon10 (AUTHOR) shlee119@skku.edu, Suwatanapongched, Thitiporn11 (AUTHOR), Kongchauy, Kanchaporn12 (AUTHOR), Ou, Qiuxiang2 (AUTHOR), Yu, Ruoying2 (AUTHOR), Tai, Bee Choo13 (AUTHOR), Goh, Boon Cher1 (AUTHOR), Mok, Tony S. K.8 (AUTHOR), Soo, Ross A.1 (AUTHOR) ross_soo@nuhs.edu.sg
Zdroj: Cancers. Oct2023, Vol. 15 Issue 20, p4999. 16p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje